Follow
Kyle Dinkins
Kyle Dinkins
Research Associate, ImmunityBio
Verified email at immunitybio.com - Homepage
Title
Cited by
Cited by
Year
A next generation bivalent human Ad5 COVID-19 vaccine delivering both spike and nucleocapsid antigens elicits Th1 dominant CD4+, CD8+ T-cell and neutralizing antibody responses
A Rice, M Verma, A Shin, L Zakin, P Sieling, S Tanaka, H Adisetiyo, J Taft, ...
BioRxiv, 2020.07. 29.227595, 2020
362020
Intranasal plus subcutaneous prime vaccination with a dual antigen COVID-19 vaccine elicits T-cell and antibody responses in mice
A Rice, M Verma, A Shin, L Zakin, P Sieling, S Tanaka, J Balint, K Dinkins, ...
Scientific Reports 11 (1), 14917, 2021
302021
Dual-antigen COVID-19 vaccine subcutaneous prime delivery with oral boosts protects NHP against SARS-CoV-2 challenge
E Gabitzsch, JT Safrit, M Verma, A Rice, P Sieling, L Zakin, A Shin, ...
Frontiers in Immunology 12, 729837, 2021
162021
Complete protection of nasal and lung airways against SARS-CoV-2 challenge by antibody plus Th1 dominant N-and S-specific T-cell responses to subcutaneous prime and thermally …
E Gabitzsch, JT Safrit, M Verma, A Rice, P Sieling, L Zakin, A Shin, ...
bioRxiv, 2020.12. 08.416297, 2020
162020
Prime hAd5 spike+ nucleocapsid vaccination induces ten-fold increases in mean T-cell responses in phase 1 subjects that are sustained against spike variants
P Sieling, T King, R Wong, A Nguyen, K Wnuk, E Gabitzsch, A Rice, ...
medRxiv, 2021.04. 05.21254940, 2021
142021
Heterologous saRNA prime, DNA dual-antigen boost SARS-CoV-2 vaccination elicits robust cellular immunogenicity and cross-variant neutralizing antibodies
A Rice, M Verma, E Voigt, P Battisti, S Beaver, S Reed, K Dinkins, S Mody, ...
Frontiers in Immunology 13, 910136, 2022
72022
The Dual-Antigen Ad5 COVID-19 Vaccine Delivered as an Intranasal Plus Subcutaneous Prime Elicits Th1 Dominant T-Cell and Humoral Responses in CD-1 Mice
A Rice, M Verma, A Shin, L Zakin, P Sieling, S Tanaka, J Balint, K Dinkins, ...
bioRxiv, 2021.03. 22.436476, 2021
52021
Single Prime Had5 Spike (s)+ Nucleocapsid (N) Dual Antigen Vaccination of Healthy Volunteers Induces a Ten-Fold Increase in Mean s-and N-T-Cell Responses Equivalent to T-Cell …
P Sieling, T King, R Wong, A Nguyen, K Wnuk, ER Gabitzsch, A Rice, ...
52021
SmRNA PRIME S+ N DNA BOOST VACCINATION ELICITS ROBUST IMMUNE RESPONSES in MICE
A Rice, M Verma, E Voigt, P Battisti, S Beaver, K Dinkins, S Mody, ...
Topics in Antiviral Medicine, 92-92, 2022
2022
Heterologous Vaccination with SARS-CoV-2 Spike saRNA Prime followed by DNA Dual-Antigen Boost Induces Robust Antibody and T-Cell Immunogenicity against both Wild Type and Delta …
A Rice, M Verma, E Voigt, P Battisti, S Beaver, S Reed, K Dinkins, S Mody, ...
bioRxiv, 2021.11. 29.470440, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–10